Long-term efficacy and safety of oral abrocitinib combined with narrow-band UVB phototherapy in non-segmental vitiligo: a 52-week prospective study
Long-term abrocitinib plus NB-UVB phototherapy demonstrates sustained efficacy and safety in progressive NSV, though non-responders by 24 weeks may not benefit from extension.
Authors
- Yuecen Ding (ORCID: https://orcid.org/0000-0002-1483-4298)
- Yijie Xuan (ORCID: https://orcid.org/0000-0002-2764-563X)
- Chengfeng Zhang (ORCID: https://orcid.org/0000-0002-1302-5667)
- Zhe Zhu
- Shanglin Jin (ORCID: https://orcid.org/0000-0002-1907-219X)
- Zhongyi Xu (ORCID: https://orcid.org/0000-0001-8158-0825)
- Leihong Flora Xiang (ORCID: https://orcid.org/0000-0003-2080-0550)
- Xuanxuan He (ORCID: https://orcid.org/0009-0007-0423-4604)
Institutions
- Fudan University (CN)
- Huashan Hospital (CN)
Publication Details
- Journal
- Journal of Dermatological Treatment
- Published
- 2025-10-17
- DOI
- https://doi.org/10.1080/09546634.2025.2574307
- Primary Topic
- melanin and skin pigmentation
- Type
- article
- Field-Weighted Citation Impact
- 0.00